within Pharmacolibrary.Drugs.ATC.J;

model J02AC02
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.55,
    Cl             = 0.005966666666666666,
    adminDuration  = 600,
    adminMass      = 200 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.01,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.007,
    Tlag           = 30.0,            
    Vdp             = 0.0184,
    k12             = 514,
    k21             = 514
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J02AC02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Itraconazole is a triazole antifungal agent used for the treatment of various fungal infections including those caused by Aspergillus, Candida, and dermatophytes. It is FDA-approved and commonly used for systemic mycoses and onychomycosis.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers following a single oral dose of 200 mg capsule under fasting conditions.</p><h4>References</h4><ol><li><p>Lennernäs, H (2003). Clinical pharmacokinetics of atorvastatin. <i>Clinical pharmacokinetics</i> 42(13) 1141–1160. DOI:<a href=\"https://doi.org/10.2165/00003088-200342130-00005\">10.2165/00003088-200342130-00005</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/14531725/\">https://pubmed.ncbi.nlm.nih.gov/14531725</a></p></li><li><p>Willems, L, et al., &amp; de Beule, K (2001). Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics. <i>Journal of clinical pharmacy and therapeutics</i> 26(3) 159–169. DOI:<a href=\"https://doi.org/10.1046/j.1365-2710.2001.00338.x\">10.1046/j.1365-2710.2001.00338.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11422598/\">https://pubmed.ncbi.nlm.nih.gov/11422598</a></p></li><li><p>Liang, C, et al., &amp; Zeng, Z (2016). Pharmacokinetics and bioavailability of itraconazole oral solution in cats. <i>Journal of feline medicine and surgery</i> 18(4) 310–314. DOI:<a href=\"https://doi.org/10.1177/1098612X15581408\">10.1177/1098612X15581408</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25916686/\">https://pubmed.ncbi.nlm.nih.gov/25916686</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J02AC02;
